PedAM
Pediatric Disease Annotations & Medicines
| Disease | ischemic stroke |
| Symptom | C0019080|hemorrhage |
| Sentences | 32 |
| PubMedID- 22811458 | Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. |
| PubMedID- 26446065 | Objective: to determine whether chronic alcohol consumption or acute alcohol intoxication affects the rate of iv thrombolysis (ivt) and associated risk of symptomatic intracranial hemorrhage (sich) in patients with acute ischemic stroke (is). |
| PubMedID- 20924291 | The disease causes ischemic stroke, intracranial hemorrhage, headache, seizures, and transient ischemia attack in children and in adults. |
| PubMedID- 25650013 | Conclusion: in this case of embolic ischemic stroke with reperfusion hemorrhage, contrast extravasation "spot sign" was associated with hematoma expansion. |
| PubMedID- 24024962 | Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: paul coverdell acute stroke registry 2008-2012. |
| PubMedID- 23644538 | Introduction: the study attempts to identify notable factors predicting poor outcome, death, and intracranial hemorrhage in patients with acute ischemic stroke undergoing mechanical thrombectomy with stent retriever. |
| PubMedID- 26150723 | Graham et al showed that dabigatran reduced the risk of ischemic stroke, intracranial hemorrhage as well as death but increased the risk of major gastrointestinal bleeding compared with warfarin in elderly patients with nvaf.20 the re-cover trial showed a rate of recurrent vte in patients treated with dabigatran (150 mg twice daily) of 2.4% compared with those treated with warfarin international normalized ratio (inr 2–3), for which the rate was 2.1%. |
| PubMedID- 22735429 | Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. |
| PubMedID- 22586418 | Vitreo-retinal hemorrhage after thrombolysis in a patient with acute ischemic stroke: a case report. |
| PubMedID- 23182902 | In a multicenter study, we demonstrated similar rates of good functional outcome and intracranial hemorrhage in patients with ischemic stroke when endovascular treatment was performed based on ct perfusion selection rather than time-guided selection. |
| PubMedID- 24876246 | Background and purpose: the aim was to investigate the risk of intracerebral hemorrhage (ich) in patients with ischemic stroke taking warfarin and whether this risk changed over time. |
| PubMedID- 25657189 | Predicting functional outcome and symptomatic intracranial hemorrhage in patients with acute ischemic stroke: a glimpse into the crystal ball. |
| PubMedID- 21266324 | This posterior fossa ischemic stroke with secondary hemorrhage caused transient obstructive hydrocephalus and likely occurred subsequent to vertebrobasilar artery thrombosis. |
| PubMedID- 25498843 | Convexity subarachnoid hemorrhage in ischemic stroke. |
| PubMedID- 24630829 | Nontraumatic convexal subarachnoid hemorrhage concomitant with acute ischemic stroke. |
| PubMedID- 21983376 | A survey of secondary prevention of ischemic stroke with intracranial hemorrhage history in chinese patients. |
| PubMedID- 23541421 | We investigated if similar rates of hemorrhage occur in patients with acute ischemic stroke (ais) of varying severity. |
| PubMedID- 26441822 | Meta-analysis of the association between symptomatic remote intracerebral hemorrhage (ich) risk in patients with acute ischemic stroke treated with intravenous thrombolysis, in relation to the presence of new cerebral microbleeds (cmbs) on mri. |
| PubMedID- 21350204 | Background and purpose: concern exists that preadmission warfarin use may be associated with an increased risk of intracerebral hemorrhage in patients with ischemic stroke receiving intravenous tissue plasminogen activator, even in those with an international normalized ratio <1.7. |
| PubMedID- 24868257 | Another multicentered study tried to stratificate the post-thrombolysis risk of cerebral hemorrhage in patients with acute ischemic stroke, who associated cmbs lesions on mri. |
| PubMedID- 25425800 | An urgent brain computed tomography (ct) revealed no intracranial hemorrhage so, a diagnosis of acute ischemic stroke was made and intravenous thrombolysis was instituted. |
| PubMedID- 26077583 | This is further backed by the strong associations of intraplaque hemorrhage with ischemic stroke and with recurrent events, as shown in previous studies. |
| PubMedID- 22973896 | The aim is to better quantify the risk of postthrombolysis intracerebral hemorrhage in patients with acute ischemic stroke and cerebral microbleeds on magnetic resonance imaging. |
| PubMedID- 24829815 | This scan showed a slight diffuse cerebral edema but no intracranial hemorrhage or early signs of ischemic stroke. |
| PubMedID- 23911995 | Rates and outcomes of neurosurgical treatment for postthrombolytic intracerebral hemorrhage in patients with acute ischemic stroke. |
| PubMedID- 21990520 | Conclusion: this study demonstrated similar rates of good functional outcome and intracranial hemorrhage in patients with ischemic stroke when endovascular treatment was performed based on ctp selection rather than time-guided selection. |
| PubMedID- 24760037 | Hemorrhagic transformation was documented when initial or follow-up brain imaging revealed hemorrhage on the site of ischemic stroke. |
| PubMedID- 23951093 | Recently, the artis trial showed that the intravenous administration of 300 mg aspirin within 90 minutes after start of intravenous thrombolysis did not improve outcome at 3 months and increased the risk of symptomatic intracerebral hemorrhage (sich) in patients with acute ischemic stroke 7. |
| PubMedID- 24337610 | The baseline dwi lesion volume has a strong prognostic value for dependency, death and intracerebral hemorrhage in patients with acute ischemic stroke including those who underwent endovascular treatment . |
| PubMedID- 25367883 | Intracerebral hemorrhagic transformation (ht) is well recognized as a common cause of hemorrhage in patients with ischemic stroke. |
| PubMedID- 23493732 | Background and purpose: to evaluate cerebral microbleeds (cmbs) and future stroke risk (including intracerebral hemorrhage ich) in patients with ischemic stroke (is) or transient ischemic attack. |
| PubMedID- 24072004 | Conclusions: the thrive score is a simple-to-use tool to predict clinical outcome, mortality, and risk of hemorrhage after thrombolysis in patients with ischemic stroke. |
Page: 1